Reaction
Adenovirus Reactivation reporting signals
As of the last recalculation, Adenovirus Reactivation appears in 137 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is FLUDARABINE PHOSPHATE (PRR 1,376.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fludarabine Phosphate | 99 | 1,376.4 | 1,379.9 |
| Thiotepa | 37 | 806.1 | 809.2 |
| Posaconazole Delayed-Release | 19 | 305.0 | 305.5 |
| Alemtuzumab | 29 | 288.7 | 289.1 |
| Posaconazole | 19 | 206.1 | 206.3 |
| Melphalan | 21 | 165.5 | 165.6 |
| Ganciclovir | 10 | 160.1 | 160.2 |
| Ganciclovir Sodium | 10 | 154.8 | 154.9 |
| Melphalan Hydrochloride | 21 | 150.1 | 150.2 |
| Sirolimus | 12 | 148.2 | 148.3 |
| Anti-Thymocyte Globulin (Rabbit) | 7 | 138.9 | 139.0 |
| Amphotericin B | 10 | 130.7 | 130.8 |
| Busulfan | 11 | 115.4 | 115.5 |
| Ifosfamide | 13 | 101.5 | 101.5 |
| Imatinib | 10 | 92.8 | 92.9 |
| Axicabtagene Ciloleucel | 3 | 47.2 | 47.2 |